Compare Kalbe Farma Tbk (KLBF) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 48.6× Charlie Hospital Semarang Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 25.57M). Which is the better fit depends on your goals.
| KLBF | RSCH | |
|---|---|---|
Market Cap | 33T | 678.4B |
Volume | 98.44M | 25.57M |
Lot | 984.38K | 255.67K |
Turnover | 70.64B | 6.57B |
Average Price | 717.58 | 256.8 |
Value | 70.64B | 6.57B |
Indicative Equilibrium Price | 720 | 258 |
Indicative Equilibrium Volume | 43.62K | 110 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
